Tag results:
lymphoid cells
Human Immunology News
Selective Delivery of Low-Affinity IL-2 to PD-1+ T Cells Rejuvenates Antitumor Immunity with Reduced Toxicity
[Journal of Clinical Investigation] Investigators observed that anti–PD-1 therapy depends on IL-2 signaling, which raised the possibility that a lack of IL-2 limited anti–PD-1–induced effector T cell expansion.
Immune Regulation News
Elongation Factor-2 Kinase Is a Critical Determinant of the Fate and Antitumor Immunity of CD8+ T Cells
[Science Advances] eEF-2K KO CD8+ T cells were more metabolically active and showed hyperactivation of the Akt-mTOR-S6K pathway.
Immune Regulation News
Aspirin Activates Resolution Pathways to Reprogram T Cell and Macrophage Responses in Colitis-Associated Colorectal Cancer
[Science Advances] The authors demonstrated that aspirin increased concentrations of the immune-regulatory aspirin-triggered (AT) specialized proresolving mediators, including AT-lipoxin A4 and AT-resolvin D1, in colonic tissues during inflammation-associated colorectal cancer.
Pulmonary Cell News
Nuclear Factor-Kappa B (NF-κB) Inhibition as a Therapeutic Target for Plant Nutraceuticals in Mitigating Inflammatory Lung Diseases
[Chemico-Biological interactions] Scientists discuss the medical value of nutraceuticals briefly and their ability to mitigate various inflammatory lung diseases through targeting inhibition of NF-κB.
Pancreatic Cell News
The Anthelmintic Drug Niclosamide Induces GSK-β-Mediated β-Catenin Degradation to Potentiate Gemcitabine Activity, Reduce Immune Evasion Ability and Suppress Pancreatic Cancer Progression
[Cell Death & Disease] Niclosamide inhibited proliferation of pancreatic cancer cells, induced apoptosis via the mitochondrial-mediated pathway, and suppressed cell migration and invasion by antagonizing epithelial-to-mesenchymal transition.
Cell Therapy News
Decade-Long Leukemia Remissions with Persistence of CD4+ CAR T Cells
[Nature] CAR T cells remained detectable more than ten years after infusion, with sustained remission in both patients.